Jones GM - Search Results

1

Adjusted versus actual body weight dosing of 4-factor prothrombin complex concentrate in obese patients with warfarin-associated major bleeding.

Smetana KS, Ziemba R, May CC, Erdman MJ, Van Matre ET, Jones GM. Smetana KS, et al. Among authors: jones gm. J Thromb Thrombolysis. 2019 Apr;47(3):369-374. doi: 10.1007/s11239-018-1771-6. J Thromb Thrombolysis. 2019. PMID: 30460443

2

Predictors of severe hypotension in neurocritical care patients sedated with propofol.

Jones GM, Doepker BA, Erdman MJ, Kimmons LA, Elijovich L. Jones GM, et al. Neurocrit Care. 2014 Apr;20(2):270-6. doi: 10.1007/s12028-013-9902-6. Neurocrit Care. 2014. PMID: 24233892

3

A comparison of severe hemodynamic disturbances between dexmedetomidine and propofol for sedation in neurocritical care patients.

Erdman MJ, Doepker BA, Gerlach AT, Phillips GS, Elijovich L, Jones GM. Erdman MJ, et al. Among authors: jones gm. Crit Care Med. 2014 Jul;42(7):1696-702. doi: 10.1097/CCM.0000000000000328. Crit Care Med. 2014. PMID: 24717468

4

The role of hormone replacement therapy in the intensive care management of deceased organ donors: a primer for nurses.

Smetana KS, Kimmons LA, Jones GM. Smetana KS, et al. Among authors: jones gm. Crit Care Nurs Q. 2015 Oct-Dec;38(4):359-70. doi: 10.1097/CNQ.0000000000000083. Crit Care Nurs Q. 2015. PMID: 26335215

5

3-Factor Versus 4-Factor Prothrombin Complex Concentrate for Warfarin Reversal in Severe Bleeding: A Multicenter, Retrospective, Propensity-Matched Pilot Study.

Jones GM, Erdman MJ, Smetana KS, Mohrien KM, Vandigo JE, Elijovich L. Jones GM, et al. J Thromb Thrombolysis. 2016 Jul;42(1):19-26. doi: 10.1007/s11239-015-1330-3. J Thromb Thrombolysis. 2016. PMID: 26721625

6

Four-Factor Versus Three-Factor Prothrombin Complex Concentrate: Is More Always Better?

Cutshall BT, Jones GM. Cutshall BT, et al. Among authors: jones gm. J Emerg Med. 2017 Apr;52(4):586-587. doi: 10.1016/j.jemermed.2016.03.042. Epub 2016 Nov 19. J Emerg Med. 2017. PMID: 27876329 No abstract available.

7

Safety of Continuous Peripheral Infusion of 3% Sodium Chloride Solution in Neurocritical Care Patients.

Jones GM, Bode L, Riha H, Erdman MJ. Jones GM, et al. Am J Crit Care. 2016 Dec;26(1):37-42. doi: 10.4037/ajcc2017439. Am J Crit Care. 2016. PMID: 27965228

8

Predictors of Acute Kidney Injury in Neurocritical Care Patients Receiving Continuous Hypertonic Saline.

Erdman MJ, Riha H, Bode L, Chang JJ, Jones GM. Erdman MJ, et al. Among authors: jones gm. Neurohospitalist. 2017 Jan;7(1):9-14. doi: 10.1177/1941874416665744. Epub 2016 Aug 29. Neurohospitalist. 2017. PMID: 28042364 Free PMC article.

9

Impact of Moderate Hyperchloremia on Clinical Outcomes in Intracerebral Hemorrhage Patients Treated With Continuous Infusion Hypertonic Saline: A Pilot Study.

Riha HM, Erdman MJ, Vandigo JE, Kimmons LA, Goyal N, Davidson KE, Pandhi A, Jones GM. Riha HM, et al. Among authors: jones gm. Crit Care Med. 2017 Sep;45(9):e947-e953. doi: 10.1097/CCM.0000000000002522. Crit Care Med. 2017. PMID: 28538442

10

Review of Continuous Infusion Neuromuscular Blocking Agents in the Adult Intensive Care Unit.

Smetana KS, Roe NA, Doepker BA, Jones GM. Smetana KS, et al. Among authors: jones gm. Crit Care Nurs Q. 2017 Oct/Dec;40(4):323-343. doi: 10.1097/CNQ.0000000000000171. Crit Care Nurs Q. 2017. PMID: 28834856 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

368 results

Search Page

Filters